Can anyone shed some light on when PYC may start trial dosing up patients suffering from PCKD?
that is the big prize ($10 billion pa) … if successful
my feeling is that is when this stock starts a sustainable improvement .. as any early indication of efficacy (without toxicity) really arcs things up
I wonder if Rohan would have had the opportunity to update FDA on the status of that program last week??
if ever a rare disease was to be given the earliest of approvals to get into patients .. it may be this drug … particularly when you think of the huge cost and number of patients just barely surviving on a life with the aid of dialysis.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)